Article Details
Retrieved on: 2019-03-13 09:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>7 analysts out of 15 Wall Street brokerage firms rate Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) as a Buy, while 2 see it as a Sell. The rest 6 ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here